Research square · 2026
Exploratory small RNA sequencing of human placental miRNAs identifies candidates associated with congenital transmission of Trypanosoma cruzi.
СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Diestra Andrea, Pando-Caciano Alejandra, Apaza-Quiroz Carla A, Adaui Vanessa, Pinedo-Cancino Viviana, Sanchez Sylvia S, Mugnier Monica, Gilman Robert H, Bowman Natalie M, Pajuelo Monica J
Аннотация
BACKGROUND: Congenital transmission remains a major source of new Chagas disease cases, yet the underlying molecular mechanisms remain poorly understood. This exploratory study aimed to identify human placental microRNAs (miRNAs) associated with congenital transmission of Trypanosoma cruzi.
METHODS: Placental samples from T. cruzi-infected mothers were classified according to congenital transmission status. Small RNA sequencing was performed on 31 placental samples, including 13 from transmitting mothers and 18 from non-transmitting mothers. Differential miRNA expression was assessed using DESeq2 with Benjamini-Hochberg false discovery rate correction. Candidate miRNAs were selected based on magnitude and significance of differential expression, or concordance with prior evidence from placental T. cruzi infection models. Selected candidates were subsequently analyzed by RT-qPCR in 15 placental samples, including 5 from transmitting mothers and 10 from non-transmitting mothers.
RESULTS: Small RNA sequencing analysis identified hsa-miR-155-5p as the only significantly upregulated miRNA in placentas from transmitting mothers compared with placentas from non-transmitting mothers (log2 fold change = 1.26; adjusted p-value = 0.024); however, RT-qPCR assessment failed to confirm it at a significant level (log2 fold change = 0.57, 1.48-fold difference; p-value = 0.426). Other miRNAs, hsa-miR-193a-5p and hsa-miR-187-3p, showed higher relative expression in transmitting mothers, with estimated log2 fold changes of 2.31 and 1.53, respectively (p = 0.032 and p = 0.043). hsa-miR-526b-3p showed a modest decrease in relative expression in transmitting mothers (log2 fold change = -0.46; p = 0.043).
CONCLUSION: Placental miRNA expression profiling of naturally infected mothers identified miRNA candidates potentially relevant to congenital transmission of T. cruzi. Given the capacity of miRNAs to regulate broad gene expression networks that influence placental biology, these results underscore the need for transcriptomic and functional studies to elucidate their regulatory relevance during T. infection and evaluate their potential as biomarkers for congenital transmission risk.
METHODS: Placental samples from T. cruzi-infected mothers were classified according to congenital transmission status. Small RNA sequencing was performed on 31 placental samples, including 13 from transmitting mothers and 18 from non-transmitting mothers. Differential miRNA expression was assessed using DESeq2 with Benjamini-Hochberg false discovery rate correction. Candidate miRNAs were selected based on magnitude and significance of differential expression, or concordance with prior evidence from placental T. cruzi infection models. Selected candidates were subsequently analyzed by RT-qPCR in 15 placental samples, including 5 from transmitting mothers and 10 from non-transmitting mothers.
RESULTS: Small RNA sequencing analysis identified hsa-miR-155-5p as the only significantly upregulated miRNA in placentas from transmitting mothers compared with placentas from non-transmitting mothers (log2 fold change = 1.26; adjusted p-value = 0.024); however, RT-qPCR assessment failed to confirm it at a significant level (log2 fold change = 0.57, 1.48-fold difference; p-value = 0.426). Other miRNAs, hsa-miR-193a-5p and hsa-miR-187-3p, showed higher relative expression in transmitting mothers, with estimated log2 fold changes of 2.31 and 1.53, respectively (p = 0.032 and p = 0.043). hsa-miR-526b-3p showed a modest decrease in relative expression in transmitting mothers (log2 fold change = -0.46; p = 0.043).
CONCLUSION: Placental miRNA expression profiling of naturally infected mothers identified miRNA candidates potentially relevant to congenital transmission of T. cruzi. Given the capacity of miRNAs to regulate broad gene expression networks that influence placental biology, these results underscore the need for transcriptomic and functional studies to elucidate their regulatory relevance during T. infection and evaluate their potential as biomarkers for congenital transmission risk.